The family of a police officer killed in the line of duty will complete the final leg of his fundraising challenge in his memory.

Dennis Haskins died at the age of 75 following a battle with Parkinson's disease. The actor played Principal Belding on ...

An experimental Parkinson’s vaccine was generally safe and triggered an immune response against aggregated alpha-synuclein in ...

Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...

Gain Therapeutics’ lead drug candidate rexaceract, formerly known as GT-02287, is in clinical development for the treatment ...

This weekend Zanies is inviting you to a comedy show for a cause!Comedian Paul Farahvar and WGN’s very own Ana Beleval are ...

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical to those living with the disease.

People living with Parkinson’s disease are hospitalized more often than other older adults, most often because of infections, falls, fractures, or other medical problems rather than Parkinson’s itself ...

Michael J. Fox established The Michael J. Fox Foundation for Parkinson's Research in 2000 after his diagnosis. The foundation has funded over $3 billion in research aimed at developing treatments and ...

AbbVie (ABBV) wins FDA approval for Juvmo, a first-in-class Parkinson's disease treatment targeting D1/D5 receptors, ...

AbbVie (ABBV) gains FDA approval for Juvmo, a first-in-class Parkinson's treatment launching October 2026. Stock dips 0.29% despite breakthrough.

AbbVie (ABBV) gains FDA approval for Juvmo, a novel Parkinson's drug using unique D1/D5 receptor targeting. U.S. launch set ...